Piper Sandler analyst Adam Maeder raised the firm’s price target on Intuitive Surgical (ISRG) to $538 from $495 and keeps an Overweight rating on the shares. The company reported Q3 results with revenue, placements, procedure growth, and adjusted earnings all coming in ahead of Street expectations, the analyst tells investors in a research note. Piper is also encouraged to see “another strong placement quarter” for DV5 and to hear Intuitive is tracking towards a broad launch in mid-2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Closing Bell Movers: Netflix gains 5% as Q3 earnings, Q4 guidance top estimates
- ISRG Earnings: Intuitive Surgical’s Financial Results Beat Estimates
- Intuitive Surgical raises FY24 procedure growth view to 16%-17% from 15.5%-17%
- Intuitive Surgical reports Q3 EPS $1.84, consensus $1.63
- Intuitive Surgical options imply 4.6% move in share price post-earnings